首页> 外国专利> The method for determining the biological activity of measles, mumps and rubella in the production of associated drugs (options)

The method for determining the biological activity of measles, mumps and rubella in the production of associated drugs (options)

机译:测定相关药物生产中麻疹,腮腺炎和风疹的生物活性的方法(可选)

摘要

1. A method for determining the biological activity of measles and rubella viruses in the production of associated preparations, comprising determining the infectious titer of production strains, characterized in that Rk-13 cell lines (transplantable rabbit kidney cell line, collection of the Scientific Research Institute) are used to determine the infectious titer of rubella virus or measles virus Virology RAS; Research Institute of Influenza RAS, Ints RAS) or L-41 (transplantable line of bone marrow cells of a person with leukemia, collections: Research Institute of Influenza RAS, Ints RAS), respectively. 2. A method for determining the biological activity of measles viruses and mumps in the production of associated preparations, characterized in that the Vero cell line is used to determine the infectious titer of production strains (African green monkey kidney transplanted cell line, collection of the Scientific Research Institute of Virology RAS; the Scientific Research Institute of Influenza, Russian Academy of Sciences, Russian Academy of Sciences) or MA-104 (transplanted culture of kidney cells of a rhesus monkey embryo, collection of the Scientific Research Institute of Virology RAS, Scientific Research Institute of Influenza RAS), while the determination of the measles virus infectious titer is carried out by the direct cytopathogenic effect of the virus on cells, and the epidemic of mumps virus by hemadsorption. 3. A method for determining the biological activity of measles, mumps and rubella viruses, characterized in that the cell line Rk-13 is used to determine the infectious titer of the production strain of rubella virus, and the Vero or MA- cell line is used to determine the infectious titer of production strains of measles virus and mumps 104, wherein the determination of measles virus infectious titer is carried out directly
机译:1.一种用于确定相关制剂的生产中的麻疹和风疹病毒的生物学活性的方法,其包括确定生产菌株的感染滴度,其特征在于Rk-13细胞系(可移植的兔肾细胞系,科学研究的集合)研究所)用于确定风疹病毒或麻疹病毒的感染滴度病毒学RAS;流感RAS研究所(Ints RAS)或L-41(白血病人的骨髓细胞可移植系,馆藏:流感RAS研究所Ints RAS)。 2.一种用于在相关制剂的生产中确定麻疹病毒和腮腺炎的生物学活性的方法,其特征在于,将Vero细胞系用于确定生产菌株的感染滴度(非洲绿猴肾移植细胞系,收集病毒学RAS科学研究所;俄罗斯科学院,俄罗斯科学院流感研究所;或MA-104(恒河猴胚胎肾细胞的移植培养物),病毒学RAS科学研究所收藏,流感科学研究所(RAS),而麻疹病毒感染滴度的测定是通过病毒对细胞的直接细胞致病作用以及通过吸血引起的腮腺炎流行来进行的。 3.一种用于确定麻疹,腮腺炎和风疹病毒的生物学活性的方法,其特征在于,使用细胞系Rk-13确定风疹病毒生产菌株的感染滴度,而Vero或MA-细胞系为用于确定麻疹病毒和腮腺炎生产菌株的感染滴度104,其中直接进行麻疹病毒感染滴度的测定

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号